Stella Diagnostics, Inc. (SLDX)

OTCMKTS · Delayed Price · Currency is USD

0.0160

0.00 (0.00%)

At close: Mar 2, 2026

-62.88% (1Y)

Market Cap	4.82M
Revenue (ttm)	n/a
Net Income (ttm)	-257.97K
Shares Out	301.51M
EPS (ttm)	-7.53
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	310
Average Volume	9,708
Open	0.0160
Previous Close	n/a
Day's Range	0.0160 - 0.0160
52-Week Range	0.0111 - 0.0520
Beta	0.25
RSI	43.31
Earnings Date	n/a

About Stella Diagnostics

Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases. It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus. The company’s technology informs gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for disease progression into precancer or cancer. The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in A... [Read more]

Industry Diagnostics & Research

Sector Healthcare

CEO David Seaburg

Employees 2

Stock Exchange OTCMKTS

Ticker Symbol SLDX

Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.